New York, Jan 27, 2026, 21:33 (EST) — Trading after hours.
- Key points:
- Rocket Lab shares climbed roughly 8% during Tuesday’s regular session before slipping slightly in after-hours trading
- A Neutron Stage 1 tank rupture has shifted focus back onto the timeline for the rocket’s inaugural flight
- Investors are eyeing Rocket Lab’s late-February earnings call for clearer details on the schedule and fresh guidance
Rocket Lab shares surged Tuesday, building on a strong bounce back following last week’s major Neutron test failure. Investors digested new contract wins and program updates linked to U.S. national security space funding. (MarketBeat)
The stock was last seen near $87, climbing from a previous close of $80.48, per Investing.com data. After-hours trading, however, showed a slight pullback. (Investing)
Rocket Lab’s stock took a big hit this week, tumbling roughly 9.5% on Monday, per Investor’s Business Daily. It bounced back the next day, though, as investors weighed the company’s plans for Neutron and overall risk appetite in U.S. markets picked up. (Investors)
Rocket Lab’s bigger, partly reusable Neutron rocket—the one meant to move the company beyond small launches—hit a snag. In a Jan. 21 press release linked to a filing, the company revealed that a hydrostatic pressure test on the first Neutron Stage 1 tank ended in a rupture. They’re now digging through the data to figure out what this means for the launch timeline. (SEC)
Rocket Lab reported no significant damage to its test facilities, with another Stage 1 tank already under production. The company noted the timeline impact depends on the data review and plans to update on Neutron’s schedule during its 2025 Q4 earnings call in February. (SEC)
Aside from the test setback, attention has turned to Rocket Lab’s expanding defense and government contracts. Investing.com reported the company secured an $816 million contract from the U.S. Space Development Agency for satellites tied to the Tracking Layer program. The outlet also highlighted that Needham boosted its price target but maintained a buy rating. (Investing)
The timeline for Neutron is crucial to Rocket Lab’s strategy, aiming to attract clients requiring more lift than the Electron can offer. This shifts them closer to competing with bigger launch providers favored for constellation and national security missions. Space.com called the fuel tank rupture a “significant setback” and noted that a first-quarter 2026 launch now seems improbable. (Space)
Analyst moves shook the tape too. MarketBeat reported Goldman Sachs raised its price target for Rocket Lab earlier this month but stuck with a neutral rating. This reflects how fast Wall Street has scrambled to update forecasts amid a flood of contract wins and emerging development risks. (MarketBeat)
The risks remain evident: Neutron hasn’t launched yet, and any further delays or an expensive redesign could dent confidence in Rocket Lab’s medium-lift capabilities and cash flow. That’s alongside its ongoing expansion in space systems and defense. (SEC)
The week underscored how quickly high-growth space stocks can react to program updates and shifts in risk appetite. Rocket Lab stood out as one of the larger decliners on Monday, dragged down alongside other speculative growth names. (Investors)
Investors are now turning their attention to Rocket Lab’s upcoming earnings report and call, set for Feb. 26, 2026. The focus will be on any updates to the Neutron rocket’s timeline, costs, and production pace, along with whether management can nail down firmer dates for the maiden flight and the subsequent production ramp. (MarketBeat)
